Measure Abbreviation
GLU-01
Data Collection Method

This measure is calculated based on data extracted from the electronic medical record combined with administrative data sources such as professional fee and discharge diagnoses data.  This measure is explicitly not based on provider self-attestation.

Measure Type
Process
Description

Percentage of cases with perioperative glucose > 200 mg/dL with administration of insulin or glucose recheck within 90 minutes of original glucose measurement.

Measure Time Period

Intraoperative

Inclusions
  • All patients with glucose level greater than 200 mg/dL between Anesthesia Start and Anesthesia End
  • Patients with and without diagnosis of diabetes
Exclusions
  • ASA 5 and 6 cases
  • Patients < 12 years of age.
  • Glucose measurements > 200 mg/dL within 90 minutes before Anesthesia End
  • Outpatient cases with Anesthesia Start to Anesthesia end time less than 4 hours long
  • Obstetric Non-Operative Procedures- CPT 01958, 01960, 01967
  • Obstetric Non-Operative Procedures with procedure text: “Labor Epidural”
Success
  • Administration of insulin within 90 minutes (either IV or sub Q routes) or
  • Recheck of glucose level within 90 minutes
Other Measure Build Details
  • Percentage of intraoperative glucose labs with perioperative glucose >200 with administration of insulin or glucose recheck within 90 minutes of original glucose measurement for the time period between Anesthesia Start and Anesthesia End.
  • For this quality measure, we selected a relatively high threshold glucose level (greater than 200 mg/dL) to alleviate concerns that patients undergoing general anesthetics are at risk of overtreatment and hypoglycemia.
  • If two blood glucose levels are documented in the same minute, the lower blood glucose will be considered for this measure
Responsible Provider

The provider signed in at the first glucose recheck or first administration of insulin. If neither occurred, then the responsible provider is the one signed in 90 minutes after the high glucose measurement.

Threshold
90%
MPOG Concept IDs Required

Insulin MPOG Concept IDs

Glucose MPOG Concept IDs

10229

Insulin Aspart

3361

POC- Glucose (Fingerstick)

10230

Insulin Glargine

3362

POC- Glucose

(Unspecified Source)

10231

Insulin Novolin

3405

POC- Blood Gas- Glucose

10232

Insulin NPH

5003

Formal Lab-Glucose,

Serum/Plasma

10233

Insulin Regular

5036

Formal Lab-Blood Gas,

Glucose

 

10659

Insulin- Unspecified

Data Diagnostics Affected
  • Percentage of Cases with Insulin Administration Mapped Correctly
  • Percentage of Cases with POC Glucose Labs
  • Percentage of Cases with a Lab Drawn during Anesthesia
  • Percentage of Labs Mapped to a Meaningful Lab Mapping
  • Percentage of Medications with a Meaningful Medication Mapping
  • Percentage of Fluids with a Meaningful Fluid Mapping
Rationale

Surgical and anesthetic stress increases hyperglycemia incidence in both diabetics and non-diabetics.3 Perioperative hyperglycemia is mediated by the release of proinflammatory cytokines (e.g., TNF-alpha and IL-6) and elevated concentrations of catecholamines, growth hormone, glucagon, and glucocorticoids.4 These mediators induce metabolic alterations in carbohydrate balance that alter peripheral glucose uptake and utilization, increase gluconeogenesis, depress glycogenesis, and induce glucose intolerance and insulin resistance.  Hyperglycemia can also be drug induced (administration of steroids).

 

Acute hyperglycemia in the perioperative period is known to increase the incidence of wound infections, overall mortality, length of stay, acute kidney injury, and delayed wound healing. 2,5,7, 8-12 Use of insulin to correct perioperative hyperglycemia decreases the risk of hospital complications and mortality in cardiac and general surgery patients.6, 12 The American Association of Clinical Endocrinologists and American Diabetes Association recommend a treatment threshold of 180 mg/dL in critically ill hospitalized patients and a preprandial blood glucose goal of 140 mg/dL in non-critically hospitalized ill patients.13 Patients undergoing anesthesia who are subject to tight glucose control are at greater risk of hypoglycemia as the effects of anesthesia can mask the symptoms of hypoglycemia and current methods of treatment and monitoring put patients at risk of overcorrection.1 A relatively high threshold glucose level (greater than 200 mg/dL) is used for this measure to alleviate concerns that patients undergoing general anesthetics are at risk of overtreatment and hypoglycemia.1 Blood glucose may be rechecked in one hour.

Risk Adjustment

Not applicable

References
    1. Akhtar, Shamsuddin, Paul G. Barash, and Silvio E. Inzucchi. 2010. “Scientific Principles and Clinical Implications of Perioperative Glucose Regulation and Control.” Anesthesia and Analgesia 110 (2): 478–97.
       
    2. Bellusse, Gislaine Cristhina, Julio Cesar Ribeiro, Isabel Cristina Martins de Freitas, and Cristina Maria Galvão. 2019. “Effect of Perioperative Hyperglycemia on Surgical Site Infection in Abdominal Surgery: A Prospective Cohort Study.” American Journal of Infection Control, December. https://doi.org/10.1016/j.ajic.2019.11.009.

 

    1. Duggan, Elizabeth W., Karen Carlson, and Guillermo E. Umpierrez. 2017. “Perioperative Hyperglycemia Management: An Update.” Anesthesiology 126 (3): 547–60.
       
    2. Esposito, Katherine, Francesco Nappo, Raffaele Marfella, Giovanni Giugliano, Francesco Giugliano, Myriam Ciotola, Lisa Quagliaro, Antonio Ceriello, and Dario Giugliano. 2002. “Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans: Role of Oxidative Stress.” Circulation 106 (16): 2067–72.
       
    3. Frisch, Anna, Prakash Chandra, Dawn Smiley, Limin Peng, Monica Rizzo, Chelsea Gatcliffe, Megan Hudson, et al. 2010. “Prevalence and Clinical Outcome of Hyperglycemia in the Perioperative Period in Noncardiac Surgery.” Diabetes Care 33 (8): 1783–88.
       
    4. Furnary, Anthony P., Guangqiang Gao, Gary L. Grunkemeier, Yingxing Wu, Kathryn J. Zerr, Stephen O. Bookin, H. Storm Floten, and Albert Starr. 2003. “Continuous Insulin Infusion Reduces Mortality in Patients with Diabetes Undergoing Coronary Artery Bypass Grafting.” The Journal of Thoracic and Cardiovascular Surgery 125 (5): 1007–21.
       
    5. Gandhi, Gunjan Y., Gregory A. Nuttall, Martin D. Abel, Charles J. Mullany, Hartzell V. Schaff, Brent A. Williams, Lisa M. Schrader, Robert A. Rizza, and M. Molly McMahon. 2005. “Intraoperative Hyperglycemia and Perioperative Outcomes in Cardiac Surgery Patients.” Mayo Clinic Proceedings. Mayo Clinic 80 (7): 862–66.
       
    6. Kotagal, Meera, Rebecca G. Symons, Irl B. Hirsch, Guillermo E. Umpierrez, E. Patchen Dellinger, Ellen T. Farrokhi, David R. Flum, and SCOAP-CERTAIN Collaborative. 2015. “Perioperative Hyperglycemia and Risk of Adverse Events among Patients with and without Diabetes.” Annals of Surgery 261 (1): 97–103.
       
    7. Kwon, Steve, Rachel Thompson, Patchen Dellinger, David Yanez, Ellen Farrohki, and David Flum. 2013. “Importance of Perioperative Glycemic Control in General Surgery: A Report from the Surgical Care and Outcomes Assessment Program.” Annals of Surgery 257 (1): 8–14.
       
    8. Mendez, Carlos E., Paul J. Der Mesropian, Roy O. Mathew, and Barbara Slawski. 2016. “Hyperglycemia and Acute Kidney Injury During the Perioperative Period.” Current Diabetes Reports 16 (1): 10.
       
    9. Ramos, Margarita, Zain Khalpey, Stuart Lipsitz, Jill Steinberg, Maria Theresa Panizales, Michael Zinner, and Selwyn O. Rogers. 2008. “Relationship of Perioperative Hyperglycemia and Postoperative Infections in Patients Who Undergo General and Vascular Surgery.” Annals of Surgery 248 (4): 585–91.
       
    10. Umpierrez, Guillermo E., Scott D. Isaacs, Niloofar Bazargan, Xiangdong You, Leonard M. Thaler, and Abbas E. Kitabchi. 2002. “Hyperglycemia: An Independent Marker of in-Hospital Mortality in Patients with Undiagnosed Diabetes.” The Journal of Clinical Endocrinology and Metabolism 87 (3): 978–82.
    11. Moghissi, Etie S., Mary T. Korytkowski, Monica DiNardo, Daniel Einhorn, Richard Hellman, Irl B. Hirsch, Silvio E. Inzucchi, et al. 2009. “American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control.” Diabetes Care 32 (6): 1119–31.
    12. Joshi, Girish P., Frances Chung, Mary Ann Vann, Shireen Ahmad, Tong J. Gan, Daniel T. Goulson, Douglas G. Merrill, Rebecca Twersky, and Society for Ambulatory Anesthesia. 2010. “Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery.” Anesthesia and Analgesia 111 (6): 1378–87.